Apoptosis and the response to anticancer therapy

被引:82
|
作者
Mow, BMF
Blajeski, AL
Chandra, J
Kaufmann, SH
机构
[1] Mayo Clin & Mayo Fdn, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Oncol Res, Rochester, MN 55905 USA
关键词
D O I
10.1097/00001622-200111000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apoptosis is a distinctive form of cell death that reflects cleavage of a subset of intracellular polypeptides by proteases known as caspases. Two major intracellular caspase cascades, one activated predominately by death receptor ligands and the other triggered by various cellular stresses, including DNA damage and microtubule disruption, have been delineated. Activation of these protease cascades is tightly regulated by a number of polypeptides, including Bcl-2 family members, inhibitor of apoptosis proteins, and several protein kinases. The demonstration that many antineoplastic agents induce apoptosis in susceptible cells raises the possibility that factors affecting caspase activation and activity might be important determinants of anticancer drug sensitivity. Here, we review recent studies describing the regulation of apoptotic pathways and identify potential implications of these findings for resistance to antineoplastic agents. Curr Opin Oncol 2001, 13:453-462 (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:453 / 462
页数:10
相关论文
共 50 条
  • [21] TNF profiles in ovarian cancer and their response to anticancer therapy
    Volodko, N
    Oleksyak, O
    Barylka, V
    Piddubnyak, V
    Bilynsky, B
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S244 - S245
  • [22] Cellular stress response and apoptosis in cancer therapy
    Herr, I
    Debatin, KM
    BLOOD, 2001, 98 (09) : 2603 - 2614
  • [23] EXAMINATION OF THE ROLE OF P53 IN TUMORIGENESIS, APOPTOSIS, AND RESPONSE TO ANTICANCER AGENTS
    LOWE, SW
    SCHMITT, EM
    RULEY, HE
    HOUSMAN, DE
    JACKS, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 98 - 98
  • [24] Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
    Huang, Jau-Ling
    Chang, Yu-Tzu
    Hong, Zhen-Yang
    Lin, Chang-Shen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [25] Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature
    Korpanty, Grzegorz
    Carbon, Juliet G.
    Grayburn, Paul A.
    Fleming, Jason B.
    Brekken, Rolf A.
    CLINICAL CANCER RESEARCH, 2007, 13 (01) : 323 - 330
  • [26] Prediction of individual response to anticancer therapy: historical and future perspectives
    Unger, Florian T.
    Witte, Irene
    David, Kerstin A.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (04) : 729 - 757
  • [27] Prediction of individual response to anticancer therapy: historical and future perspectives
    Florian T. Unger
    Irene Witte
    Kerstin A. David
    Cellular and Molecular Life Sciences, 2015, 72 : 729 - 757
  • [28] Prediction and Early Evaluation of Anticancer Therapy Response: From Imaging of Drug Efflux Pumps to Targeted Therapy Response
    Meng, Qingqing
    Li, Zheng
    Li, Shaoshun
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (41) : 4625 - 4638
  • [29] APOPTOSIS INDUCED BY ANTICANCER DRUGS
    HICKMAN, JA
    CANCER AND METASTASIS REVIEWS, 1992, 11 (02) : 121 - 139
  • [30] Regulators of apoptosis as anticancer targets
    Tolcher, AW
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2002, 16 (05) : 1255 - +